Activation of fibroblast-derived matrix metalloproteinase-2 by colon- cancer cells in non-contact co-cultures

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 165-171

  Ko, Kohaku ^a   Yazumi, Shujiro ^a   Yoshikawa, Kiyotsugu ^a   Konda, Yoshitaka ^a   Nakajima, Motowo ^b   Chiba, Tsutomu ^a   Takahashi, Rei ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NOVARTIS PHARMA K K   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CGS 27023A; EDETIC ACID; GELATINASE A; MATRIX METALLOPROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; COCULTURE; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BASEMENT MEMBRANE; BLOTTING, NORTHERN; CACO-2 CELLS; CELL LINE; CELL MEMBRANE; CHELATING AGENTS; COCULTURE TECHNIQUES; COLONIC NEOPLASMS; EDETIC ACID; ENZYME ACTIVATION; FIBROBLASTS; GELATIN; HUMANS; HYDROXAMIC ACIDS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; PROTEASE INHIBITORS; PYRAZINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SULFONAMIDES; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TUMOR CELLS, CULTURED;

EID: 0034661753     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<165::AID-IJC2>3.0.CO;2-F     Document Type: Article

References (33)

1. AGREZ, M.V., BATES, R.C., MITCHELL, D., WILSON, N., FERGUSON, N., ANSELINE, P. and SHEPPARD, D., Multiplicity of fibronectin-binding alpha-V-integrin receptors in colorectal cancer. Brit. J. Cancer, 73, 887-892 (1996).
2. BIRKEDAL-HANSEN, H., MOORE, W.G., BODDEN, M.K., WINDSOR, L.J., BIRKEDAL-HANSEN, B., DECARLO, A. and ENGLER, J.A., Matrix metalloproteinases: a review. Crit. Rev. oral Biol. Med., 4, 197-250 (1993).
3. BOYD, R.S. and BALKWILL, F.R., MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Brit. J. Cancer, 80, 315-321 (1999).
4. 3. Cell, 85, 683-693 (1996).
5. DERYUGINA, E.I., BOURDON, M.A., REISFELD, R.A. and STRONGIN, A., Remodeling of collagen matrix by human tumor cells requires activation and cell-surface association of matrix metalloproteinase-2. Cancer Res., 58, 3743-3750 (1998).
6. ELLERBROEK, S.M., FISHMAN, D.A., KEARNS, A.S., BAFETTI, L.M. and STACK, M.S., Ovarian-carcinoma regulation of matrix metalloproteinase-2 and membrane type-1 matrix metalloproteinase through beta1 integrin. Cancer Res., 59, 1635-1641 (1999).
7. EMONARD, H.P., REMACLE, A.G., NOEL, A.C., GRIMAUD, J.A., STETLER-STEVENSON, W.G. and FOIDART, J.M., Tumor-cell-surface-associated binding site for the M(r) 72,000 type-IV collagenase. Cancer Res., 52, 5845-5848 (1992).
8. FABRA, A., NAKAJIMA, M., BUCANA, C.D. and FIDLER, I.J., Modulation of the invasive phenotype of human colon-carcinoma cells by organ-specific fibroblasts of nude mice. Differentiation, 52, 101-110 (1992).
9. IMPER, V. and VAN WART, H., Substrate specificity and mechanism of substrate recognition of the matrix metalloproteinases. In: W.C. Parks and R.P. Mecham (eds.), Matrix metalloproteinases, pp. 219-242, Academic Press, San Diego (1998).
10. ITOH, Y., ITO, A., IWATA, K., TANZAWA K., MORI, Y. and NAGASE, H., Plasma-membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J. biol. Chem., 273, 24360-24367 (1998).
11. KATAOKA, H., DECASTRO, R., ZUCKER, S. and BISWAS, C., Tumor-cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res., 53, 3154-3158 (1993).
12. KINOSHITA, T., SATO, H., OKADA, A., OHUCHI, E., IMAI, K., OKADA, Y. and SEIKI, M., TIMP-2 promotes activation of progelatinase A by membrane-type-1 matrix metalloproteinase immobilized on agarose beads. J. biol. Chem., 273, 16098-16103 (1998).
13. KITADAI, Y., BUCANA, C.D., ELLIS, L.M., ANZAI, H., TAHARA, E. and FIDLER, I.J., In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon-carcinoma cells. Amer. J. Pathol., 147, 1238-1247 (1995).
14. LEE, A.Y., AKERS, K.T., COLLIER, M., LI, L., EISEN, A.Z. and SELTZER, J.L., Intracellular activation of gelatinase A (72-kDa type-IV collagenase) by normal fibroblasts. Proc. nat. Acad. Sci. (Wash.). 94, 4424-4429 (1997).
15. LEHTI, K., LOHI, J., VALTANEN, H. and KESKI-OJA, J., Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase-A activation at the cell surface. Biochem. J., 334, 345-353 (1998).
16. r 72,000 type-IV collagenase in human colonic adenocarcinoma. Cancer Res., 51, 439-444 (1991).
17. MAZZIERI, R., MASIERO, L., ZANETTA, L., MONEA, S., ONISTO, M., GARBISA, S. and MIGNATTI, P., Control of type-IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. EMBO J., 16, 2319-2332 (1997).
18. NAKAHARA, H., HOWARD, L., THOMPSON, E.W., SATO, H., SEIKI, M., YEH, Y. and CHEN, W.T., Transmembrane/cytoplasmic-domain-mediated membrane-type-1-matrix-metalloprotease docking to invadopodia is required for cell invasion. Proc. nat. Acad. Sci. (Wash.), 94, 7959-7964 (1997).
19. NOMURA, H., FUJIMOTO, N., SEIKI, M., MAI, M. and OKADA, Y., Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int. J. Cancer, 69, 9-16 (1996).
20. OHTANI, H., MOTOHASHI, H., SATO, H., SEIKI, M. and NAGURA, H., Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immuno-electron microscopy. Int. J. Cancer, 68, 565-570 (1996).
21. OKADA, A., BELLOCQ, J.P., ROUYER, N., CHENARD, M.P., RIO, M.C., CHAMBON, P. and BASSET, P., Membrane-type matrix-metalloproteinase(MT-MMP) gene is expressed in stromal cells of human colon, breast, and head- and-neck carcinomas. Proc. nat. Acad. Sci. (Wash.), 92, 2730-2734 (1995).
22. PARSONS, S.L., WATSON, S.A., COLLINS, H.M., GRIFFIN, N.R., CLARKE, P.A. and STEELLE, R.J., Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Brit. J. Cancer, 78, 1495-1502 (1998).
23. PEI, D., Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J. biol. Chem., 274, 8925-8932 (1999).
24. RING, P., JOHANSSON, K., HOYHTYA, M., RUBIN, K. and LINDMARK, G., Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer - a predictor of tumour stage. Brit. J. Cancer, 76, 805-811 (1997).
25. SATO, H., TAKINO, T., KINOSHITA, T., IMAI, K., OKADA, Y., STETLER-STEVENSON, W.G. and SEIKI, M., Cell-surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett., 385, 238-240 (1996).
26. SATO, H., TAKINO, T., OKADA, Y., CAO, J., SHINAGAWA, A., YAMAMOTO, E. and SEIKI, M., A matrix metalloproteinase expressed on the surface of invasive tumour cells (comments). Nature (Lond.), 370, 61-65 (1994).
27. SEGAIN, J.P., HARB, J., GREGOIRE, M., MEFLAH, K. and MENANTEAU, J., Induction of fibroblast gelatinase-B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res., 56, 5506-5512 (1996).
28. SHOFUDA, K., MORIYAMA, K., NISHIHASHI, A., HIGASHI, S., MIZUSHIMA, H., YASUMITSU, H., MIKI, K., SATO, H., SEIKI, M. and MIYAZAKI, K., Role of tissue inhibitor of metalloproteinases-2 (TIMP-2) in regulation of progelatinase-A activation catalyzed by membrane-type matrix metalloproteinase-1 (MT1-MMP) in human cancer cells. J. Biochem. (Tokyo), 124, 462-470 (1998).
29. STRONGIN, A.Y., COLLIER, I., BANNIKOV, G., MARMER, B.L., GRANT, G.A. and GOLDBERG, G.I., Mechanism of cell-surface activation of 72-kDa type-IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. biol. Chem., 270, 5331-5338 (1995).
30. STRONGIN, A.Y., MARMER, B.L., GRANT, G.A. and GOLDBERG, G.I., Plasma-membrane-dependent activation of the 72-kDa type-IV collagenase is prevented by complex formation with TIMP-2. J. biol. Chem., 268, 14033-14039 (1993).
31. THÉRET, N., MUSSO, O., L'HELGOUALC'H, A. and CLEMENT, B., Activation of matrix metalloproteinase-2 from hepatic stellate cells requires interactions with hepatocytes. Amer. J. Pathol., 150, 51-58 (1997).
32. TSO, P. and BALINT, J.A., Formation and transport of chylomicrons by enterocytes to the lymphatics. Amer. J. Physiol., 250, G715-G726 (1986).
33. YONEDA, T., SASAKI, A., DUNSTAN, C., WILLIAMS, P.J., BAUSS, F., DE CLERCK, Y.A. and MUNDY, G.R., Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J. clin. Invest., 99, 2509-2517 (1997).